| Name | GAS5 antisense RNA 1 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n GAS5‐AS1 is a long noncoding RNA that appears to act predominantly as a tumor suppressor and regulator of cell differentiation in multiple disease contexts. In non‐small cell lung cancer, GAS5‐AS1 is downregulated relative to normal tissue, and its reduced expression correlates with larger tumors, higher TNM stages, and increased lymph node metastasis; functionally, forced expression of GAS5‐AS1 inhibits cell migration and invasion by decreasing key epithelial–mesenchymal transition (EMT) markers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In hepatocellular carcinoma, lower levels of GAS5‐AS1 are associated with poor differentiation, advanced TNM stage, and unfavorable overall survival, suggesting its potential as a diagnostic and prognostic biomarker."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Similarly, in cervical cancer, GAS5‐AS1 expression is markedly decreased compared to adjacent normal tissues. Its downregulation correlates with advanced disease stage, metastasis, and poor prognosis, while experimental upregulation of GAS5‐AS1 suppresses proliferation, migration, and invasion. Mechanistically, it interacts with the tumor suppressor GAS5, enhancing its stability through modulation of RNA demethylation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond its roles in malignancy, GAS5‐AS1 also participates in non‐cancerous regulatory networks. It has been identified as a regulatory factor in human adipose‐derived stem cells, where it is part of a competing endogenous RNA network that modulates adipocytokine and IL‑17 signaling pathways to promote proliferation and adipogenic differentiation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Moreover, GAS5‐AS1 has emerged from transcriptomic studies as a component of ceRNA networks involved in type 1 diabetes mellitus, where it may influence insulin signaling and related pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Its inclusion in immune‐related prognostic signatures for cervical cancer further underscores the clinical significance of GAS5‐AS1 as a potential biomarker for patient outcome."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Finally, in the context of oral submucous fibrosis, a precancerous condition, GAS5‐AS1 is significantly reduced in affected tissues, and its overexpression diminishes myofibroblast activity and collagen contractility—effects that may be mediated via inhibition of Smad signaling—thereby implicating GAS5‐AS1 in fibrogenesis and disease progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ying Wu, Hui Lyu, Hongbing Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep31093"}], "href": "https://doi.org/10.1038/srep31093"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27489122"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27489122"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yingchao Wang, Wei Jing, Weijie Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biomark (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/CBM-170781"}], "href": "https://doi.org/10.3233/CBM-170781"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29660898"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29660898"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xiao Wang, Junjun Zhang, Yan Wang "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA GAS5-AS1 suppresses growth and metastasis of cervical cancer by increasing GAS5 stability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Transl Res (2019)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31497208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31497208"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Fang-Tian Xu, Yin-Li Xu, Yong-Xian Rong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rg1 Promotes the Proliferation and Adipogenic Differentiation of Human Adipose-Derived Stem Cells "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "via"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " FXR1/Lnc-GAS5-AS1 Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Stem Cell Res Ther (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/1574888X16666211129121414"}], "href": "https://doi.org/10.2174/1574888X16666211129121414"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34844547"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34844547"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Qinghong Shi, Hanxin Yao "}, {"type": "b", "children": [{"type": "t", "text": "Signature RNAS and related regulatory roles in type 1 diabetes mellitus based on competing endogenous RNA regulatory network analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Med Genomics (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12920-021-00931-0"}], "href": "https://doi.org/10.1186/s12920-021-00931-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34006268"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34006268"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Qian Chen, Lang Hu, Dongping Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Six-lncRNA Immune Prognostic Signature for Cervical Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Genet (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fgene.2020.533628"}], "href": "https://doi.org/10.3389/fgene.2020.533628"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33173530"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33173530"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Che-Yi Lin, Yi-Wen Liao, Pei-Ling Hsieh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA GAS5-AS1 inhibits myofibroblasts activities in oral submucous fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Formos Med Assoc (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jfma.2017.09.012"}], "href": "https://doi.org/10.1016/j.jfma.2017.09.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29249416"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29249416"}]}]}]}
|
| NCBI Gene ID | 100506046 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
GAS5-AS1 has 261 functional associations with biological entities spanning 3 categories (organism, chemical, cell line, cell type or tissue) extracted from 6 datasets.
Click the + buttons to view associations for GAS5-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of GAS5-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of GAS5-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of GAS5-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of GAS5-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of GAS5-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of GAS5-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |